Automotive Collision Repair Market Enormous Growth Insights |

Automotive Collision Repair Market Enormous Growth

Automotive Collision Repair Market Size 2020 | Analysis, Trends, Top Manufacturers, Growth, Statistics, Porters Five Forces and SWOT Analysis, Opportunities and Forecast

California – According to report published by Data Bridge Market Research, The Automotive Collision Repair market size is expected to reach USD XX billion in the forecast period. This Automotive Collision Repair Market delivers detailed overview in terms of market segmentation By Product Type (Paint & Coatings, Consumables, Spare Parts), Service Channel (Do-It-Yourself, Do-It-For-Me, Original Equipment), Vehicle Type (Light- Duty Vehicle, Heavy Duty Vehicle, Two Wheelers), End- User (New OEM, Aftermarket, Recycled, Remanufactured), Auto Body Shops (Dealer Owned Shops, Independent Repair Shops), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia,

Read More

Read More

Insights on the Worldwide Mobile Access Control Platform Market to 2027

DUBLIN, Oct. 6, 2020 /PRNewswire/ — The “Mobile Access Control Platform Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Technology and Application” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo
Research and Markets Logo

According to this report the market was valued at US$ 122.1 million in 2019 and is projected to reach US$ 782.0 million by 2027; it is expected to grow at a CAGR of 27.1% from 2019 to 2027.

The report highlights the key factors driving the market growth, and prominent players and their developments in the market.

The mobile-based access control apps offer secured access to rooms, buildings and different areas to users via mobile access control, with just a few clicks on their mobile devices, such as smartphones, tablets, and wearable devices. Increase in penetration of smartphones, implementation of the Internet of things (IoT), and rise in concern related to security and

Read More

Read More

CAR-T Pipeline Insights Report 2020: Comprehensive Insights on 250+ Companies and Pipeline Drugs – ResearchAndMarkets.com | Business

DUBLIN–(BUSINESS WIRE)–Sep 23, 2020–

The CAR-T – Pipeline Insight, 2020, report provides comprehensive insights about 250+ companies and 250+ pipeline drugs in CAR-T pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

CAR-T is a type of treatment in which a patient’s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and

Read More

Read More

CAR-T Pipeline Insights Report 2020: Comprehensive Insights on 250+ Companies and Pipeline Drugs – ResearchAndMarkets.com – Press Release

DUBLIN–(Business Wire)–The “CAR-T – Pipeline Insight, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.

The CAR-T – Pipeline Insight, 2020, report provides comprehensive insights about 250+ companies and 250+ pipeline drugs in CAR-T pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

CAR-T: Overview

CAR-T is a type of treatment in which a patient’s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR).

Read More

Read More